{"id":"NCT02757352","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis","officialTitle":"A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-08-02","primaryCompletion":"2019-03-01","completion":"2019-05-07","firstPosted":"2016-05-02","resultsPosted":"2020-03-13","lastUpdate":"2020-03-13"},"enrollment":303,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Axial Spondyloarthritis"],"interventions":[{"type":"DRUG","name":"Ixekizumab","otherNames":["LY2439821"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Q2W Ixekizumab","type":"EXPERIMENTAL"},{"label":"Q4W Ixekizumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) na√Øve participants with nonradiographic axial spondyloarthritis (nonrad-axSpA).","primaryOutcome":{"measure":"Percentage of Participants Achieving an Assessment of Spondyloarthritis International Society 40 (ASAS40) Response","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo","deltaMin":19,"sd":null},{"arm":"Ixekizumab 80 mg Q4W","deltaMin":35.4,"sd":null},{"arm":"Ixekizumab 80 mg Q2W","deltaMin":40.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.009"},{"comp":"OG000 vs OG002","p":"0.002"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":10},"locations":{"siteCount":109,"countries":["United States","Argentina","Austria","Brazil","Canada","Czechia","Finland","Germany","Japan","Mexico","Netherlands","Poland","Puerto Rico","Romania","Russia","South Korea"]},"refs":{"pmids":["40694276","38288892","36792107","36282526","35429281","34560906","33284423","33044756","31813637"],"seeAlso":["http://www.lillytrialguide.com/en-US/studies/nonradiographic-axial%20spondyloarthritis/RHBX#?postal="]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":104},"commonTop":["Nasopharyngitis","Injection site reaction","Upper respiratory tract infection","Bronchitis","Pharyngitis"]}}